Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act.
Support for site neutrality policies in H.R.5378 - Lower Costs, More Transparency Act
Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act.
H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
Support the passage of the Seniors' Access to Critical Medications Act (H.R. 5526, S. 3458)
H.R. 3284, the Providers and Payers COMPETE Act.
H.R.6683 - Preserving Seniors Access to Physicians Act of 2023
Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Safe Step Act.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Duration: February 15, 2014
to
present
General Issues: Medicare/Medicaid , Health Issues , Small Business
Spending: about $2,380,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on April 22.
Original Filing: 301575875.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act.
Support for site neutrality policies in H.R.5378 - Lower Costs, More Transparency Act
Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act.
H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
Support the passage of the Seniors' Access to Critical Medications Act (H.R. 5526, S. 3458)
H.R. 3284, the Providers and Payers COMPETE Act.
H.R.6683 - Preserving Seniors Access to Physicians Act of 2023
Agencies Lobbied
U.S. Senate
Lobbying Issues
Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Safe Step Act.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on Jan. 20.
Original Filing: 301533990.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act.
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023.
Support for site neutrality policies in H.R.5378 - Lower Costs, More Transparency Act
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act.
H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
Support the passage of the Seniors' Access to Critical Medications Act (H.R. 5526, S. 3458)
H.R.2880 - Protecting Patients Against PBM Abuses Act
H.R. 3284, the Providers and Payers COMPETE Act.
H.R.6683 - Preserving Seniors Access to Physicians Act of 2023
Agencies Lobbied
U.S. Senate
Lobbying Issues
Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Safe Step Act.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Patient access to colonoscopy procedures in commercial insurance.
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on Oct. 20, 2023.
Original Filing: 301516552.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act.
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023.
Support for site neutrality policies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act.
Issues related to ASP and H.R.5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in the Expanded Telehealth Access Act and the Telehealth Modernization Act
Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Safe Step Act.
H.R. 3284, the Providers and Payers COMPETE Act.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Patient access to colonoscopy procedures in commercial insurance.
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, H.R.2880 - Protecting Patients Against PBM Abuses Act.
S.2764/H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act of 2023
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on July 20, 2023.
Original Filing: 301490197.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act.
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023.
Support for site neutrality policies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in the Expanded Telehealth Access Act and the Telehealth Modernization Act
Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Safe Step Act.
H.R. 3284, the Providers and Payers COMPETE Act.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Patient access to colonoscopy procedures in commercial insurance.
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on April 20, 2023.
Original Filing: 301466775.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in the Expanded Telehealth Access Act and Telehealth Modernization Act.
Support for site neutrality policies.
Provisions included in Title I - Subtitle B of Public Law No: 117-169/H.R. 5376 - Inflation Reduction Act of 2022.
Support for Sec. 4113 - Advancing Telehealth Beyond COVID-19 included in H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. No: 117-328).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in the Expanded Telehealth Access Act and the Telehealth Modernization Act
Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Safe Step Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438301.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Support for site neutrality policies.
Provisions included in Title I - Subtitle B of Public Law No: 117-169/H.R. 5376 - Inflation Reduction Act of 2022.
Issues related to payments cuts to the Medicare Physician Fee Schedule including in H.R.8800 - Supporting Medicare Providers Act of 2022 and Sec. 4112 of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. No: 117-328).
Support for Sec. 4113 - Advancing Telehealth Beyond COVID-19 included in H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. No: 117-328).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Policies to remove barriers to physician prescribing decisions including in H.R. 2163/S. 464 - Safe Step Act of 2021.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on Oct. 20, 2022.
Original Filing: 301415159.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Support for site neutrality policies.
Provisions included in Title I - Subtitle B of Public Law No: 117-169/H.R. 5376 - Inflation Reduction Act of 2022.
Issues related to physician payments including in H.R.8800 - Supporting Medicare Providers Act of 2022.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Policies to remove barriers to physician prescribing decisions including in H.R. 2163/S. 464 - Safe Step Act of 2021.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on July 20, 2022.
Original Filing: 301390187.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Support for site neutrality policies.
Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act and Senate reconciliation bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Policies to remove barriers to physician prescribing decisions including in H.R. 2163/S. 464 - Safe Step Act of 2021.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on April 20, 2022.
Original Filing: 301365164.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Support for site neutrality policies.
Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on Jan. 20, 2022.
Original Filing: 301335838.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Issues related to physician payment cuts addressed in S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6143 - Supporting Health Care Providers During the COVID-19 Pandemic Act.
Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on Oct. 20, 2021.
Original Filing: 301311429.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on July 20, 2021.
Original Filing: 301284688.xml
Lobbying Issues
Access and reimbursement of Part B Drugs in Medicare.
Extension to Medicare sequester delay in S. 748 - A Bill to Provide for an Extension of the Temporary Suspension of Medicare Sequestration During the COVID-19 Public Health Emergency, H.R. 1868 - To Prevent Across-The-Board Direct Spending Cuts, and For Other Purposes, H.R. 315 - Medicare Sequester COVID Moratorium Act and H.R.1999 - To delay and offset the sequester under the Statutory Pay-As-You-Go Act of 2010 as a result of the enactment of the American Rescue Plan Act of 2021, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued expansion of Telehealth services including in H.R. 2168 - Expanded Telehealth Access Act and S. 368/H.R. 1332 - Telehealth Modernization Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $70,000. The report was filed on April 20, 2021.
Original Filing: 301264421.xml
Lobbying Issues
Continued expansion of Telehealth services.
Extension to Medicare sequester delay in S. 748 - A Bill to Provide for an Extension of the Temporary Suspension of Medicare Sequestration During the COVID-19 Public Health Emergency, H.R. 1868 - To Prevent Across-The-Board Direct Spending Cuts, and For Other Purposes, H.R. 315 - Medicare Sequester COVID Moratorium Act and H.R.1999 - To delay and offset the sequester under the Statutory Pay-As-You-Go Act of 2010 as a result of the enactment of the American Rescue Plan Act of 2021, and for other purposes.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234741.xml
Lobbying Issues
Provisions related to Medicare coinsurance for colorectal cancer screenings in H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019 and Division CC Sec. 122 of H.R. 133 Consolidated Appropriations Act of 2020.
Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019.
Reform to Stark Law and anti-kickback statute in Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694).
Implementation of Public Law 116-136.
Most Favored Nation (MFN) Model, (CMS-5528-IFC).
Changes to evaluation and management coding redistribution in Revisions to Payment Policies under the Medicare Physician Fee Schedule, Quality Payment Program and Other Revisions to Part B for CY 2021 (CMS-1734-F), H.R. 8702/S. 5007 - Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, and Division CC Section 113 and Division N Section 101 of H.R. 133 - Consolidated Appropriations Act, 2020.
Extension of Medicare Sequester Delay in Division N Sec. 102 of H.R. 133.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Oct. 14, 2020.
Original Filing: 301209606.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019.
Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019.
Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694).
Implementation of Public Law 116-136.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on July 14, 2020.
Original Filing: 301187530.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019.
Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019.
Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019.
Opposition to step therapy requirement in Medicare Advantage.
Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694).
S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019.
Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Paycheck Protection Program and H.R. 7010/ S. 3805, the Paycheck Protection Flexibility Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on April 19, 2020.
Original Filing: 301172493.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019.
Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019.
Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019.
Opposition to step therapy requirement in Medicare Advantage.
Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694).
S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019.
The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
The Paycheck Protection Program in H.R. 748, the CARES Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
THE MCMANUS GROUP amended a lobbying report for representation of Digestive Health Physicians Association, Inc. in Q12020 on April 19, 2020.
Original Filing: 301172528.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019.
Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019.
Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019.
Opposition to step therapy requirement in Medicare Advantage.
Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694).
S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019.
The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
The Paycheck Protection Program in H.R. 748, the CARES Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108688.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019.
Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019.
Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019.
Opposition to step therapy requirement in Medicare Advantage.
Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694).
S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and H.R. 19, the Lower Costs, More Cures Act of 2019.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Oct. 21, 2019.
Original Filing: 301073436.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on July 16, 2019.
Original Filing: 301046798.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on April 22, 2019.
Original Filing: 301033494.xml
Lobbying Issues
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Jan. 22, 2019.
Original Filing: 301017214.xml
Lobbying Issues
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017. Opposition to step therapy requirement in Medicare Advantage.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991435.xml
Lobbying Issues
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017. Opposition to step therapy requirement in Medicare Advantage.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on July 20, 2018.
Original Filing: 300974577.xml
Lobbying Issues
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on April 20, 2018.
Original Filing: 300955198.xml
Lobbying Issues
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Jan. 19, 2018.
Original Filing: 300929329.xml
Lobbying Issues
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910311.xml
Lobbying Issues
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Support for Stark self referral reform. Opposition to H.R. 2066 - PIMA of 2017.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on July 20, 2017.
Original Filing: 300894390.xml
Lobbying Issues
H.R. 1017: Removing Barriers to Colorectal Cancer Screening Act of 2017. Preserve the in-office ancillary exception. Support for Stark self referral reform. Opposition to H.R. 2066 - PIMA of 2017.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $60,000. The report was filed on April 20, 2017.
Original Filing: 300876637.xml
Lobbying Issues
H.R. 1017: Removing Barriers to Colorectal Cancer Screening Act of 2017. Preserve the in-office ancillary exception. Support for Stark self referral reform.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on Jan. 19, 2017.
Original Filing: 300851799.xml
Lobbying Issues
H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Opposition to proposed Part B demo (81 FR 13229). MACRA Implementation (81 FR 28161). Support for H.R.5122 - To prohibit further action on the proposed rule regarding testing of Medicare Part B prescription drug models. Opposition to H.R.5088 - PIMA of 2016. Sec. 4001, electronic health fairness provision H.R.34 - 21st Century Cures Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on Oct. 19, 2016.
Original Filing: 300833967.xml
Lobbying Issues
H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Opposition to proposed Part B demo (81 FR 13229). MACRA Implementation (81 FR 28161). EHR Provision in HR 5273 -Helping Hospitals Improve Patient Care Act of 2016. Support for H.R.5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on July 19, 2016.
Original Filing: 300814135.xml
Lobbying Issues
H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Education and advocacy regarding proposed colonoscopy cuts in CY 2016 Proposed Rule for Medicare Physician Fee Schedule. Opposition to proposed Part B demo (81 FR 13229). MACRA Implementation (81 FR 28161). EHR Provision in HR 5273 -Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
THE MCMANUS GROUP amended a lobbying report for representation of Digestive Health Physicians Association, Inc. in Q12016 on June 30, 2016.
Original Filing: 300806335.xml
Lobbying Issues
H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Education and advocacy regarding proposed colonoscopy cuts in CY 2016 Proposed Rule for Medicare Physician Fee Schedule. S.2425, Patient Access and Medicare Protection Act. Opposition to proposed Part B demo (81 FR 13229)
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on April 20, 2016.
Original Filing: 300800597.xml
Lobbying Issues
H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Education and advocacy regarding proposed colonoscopy cuts in CY 2016 Proposed Rule for Medicare Physician Fee Schedule. S.2425, Patient Access and Medicare Protection Act. Opposition to proposed Part B demo (81 FR 13229)
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on Jan. 20, 2016.
Original Filing: 300783247.xml
Lobbying Issues
H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Education and advocacy regarding proposed colonoscopy cuts in CY 2016 Proposed Rule for Medicare Physician Fee Schedule. S.2425, Patient Access and Medicare Protection Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on Oct. 20, 2015.
Original Filing: 300763752.xml
Lobbying Issues
Prevent changes to in office ancillary services exception.H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015. Education and advocacy regarding proposed colonoscopy cuts in CY 2016 Proposed Rule for Medicare Physician Fee Schedule.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on July 20, 2015.
Original Filing: 300745215.xml
Lobbying Issues
Prevent changes to in office ancillary services exception.H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.887 & S.1347 - Electronic Health Fairness Act of 2015
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $50,000. The report was filed on April 20, 2015.
Original Filing: 300722352.xml
Lobbying Issues
Prevent changes to in office ancillary services exception.H.R. 1220: Removing Barriers to Colorectal Cancer Screening Act of 2015. S. 624: Removing Barriers to Colorectal Cancer Screening Act of 2015. Support H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $30,000. The report was filed on Jan. 20, 2015.
Original Filing: 300704566.xml
Lobbying Issues
Prevent changes to in office ancillary services exception. HR 1070, "Removing Barriers to Colorectal Cancer Screening Act of 2013," and S 2348, "Removing Barriers to Colorectal Cancer Screening Act of 2014." Greater transparency in CMS rulemaking.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $30,000. The report was filed on Oct. 20, 2014.
Original Filing: 300686966.xml
Lobbying Issues
Prevent changes to in office ancillary services exception. HR 1070, "Removing Barriers to Colorectal Cancer Screening Act of 2013," and S 2348, "Removing Barriers to Colorectal Cancer Screening Act of 2014." Greater transparency in CMS rulemaking.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $30,000. The report was filed on July 17, 2014.
Original Filing: 300659689.xml
Lobbying Issues
Prevent changes to in office ancillary services exception. HR 1070, "Removing Barriers to Colorectal Cancer Screening Act of 2013," and S 2348, "Removing Barriers to Colorectal Cancer Screening Act of 2014."
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, THE MCMANUS GROUP lobbied for Digestive Health Physicians Association, Inc. , earning $20,000. The report was filed on April 21, 2014.
Original Filing: 300647923.xml
Lobbying Issues
Prevent changes to in office ancillary services exception. Payment reform issues in H.R.4302 "Protecting Access to Medicare Act of 2014," HR 4015 "SGR Repeal and Medicare Provider Payment Modernization Act of 2014," S.2110 "Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014," S.1871 & H.R. 2810 "SGR Repeal and Medicare Beneficiary Access Act of 2013," and S. 2000 "SGR Repeal and Medicare Provider Payment Modernization Act of 2014."
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...